Evidence map›Paper›PMID 41157154›Full record

ReviewMolecules (Basel, Switzerland)2025

Development of Nanotechnological Approaches to Improving the Antimalarial Potential of Natural Substances.

Yoana Yoncheva, Lyubomira Radeva, Krassimira Yoncheva

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoana YonchevaFaculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
Lyubomira RadevaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-3456-7027
Krassimira YonchevaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0003-2704-3054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is one of the diseases that is a serious threat to global health, with millions of cases reported worldwide in recent years. The treatment of malaria is still a challenge due to its complex pathogenesis, resistance to many of the antimalarial drugs, and adverse toxicity. Nowadays, the possibilities of applying new natural molecules alone or in combination is being researched. However, many of these substances possess low aqueous solubility, which limits their bioavailability. The solubility of such substances could be improved by applying various techniques for their nanoencapsulation, e.g., incorporation in nanocapsules, liposomes, lipid nanoparticles, etc. The current review emphasizes studies on the nanoencapsulation of some of the well-known natural antimalarial agents (quinine, artemisinin) as well as substances with newly demonstrated antimalarial potential (piperine, quercetin, etc.). The review also discusses the opportunity to simultaneously load two natural agents in nanoparticles. Special focus is given to the metal nanoparticles (e.g., silver, gold, etc.) obtained by green synthesis from plants.

Indexed as

AntimalarialsBiological ProductsMalariaNanotechnologyAnimalsHumansLiposomesMetal NanoparticlesNanoparticlesAntimalarialsBiological ProductsLiposomesmalariametal nanoparticlesnanoencapsulationnatural antimalarial drugs

Identifiers

PMID41157154
PMCPMC12565865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.